Furthermore, when patients were subdivided according to disease duration, presence of lung fibrosis, pulmonary hypertension, digital ulcers, or specific autoantibodies, no significant difference was observed in sCD163 concentration. The gene discussed is CD163; the disease is pulmonary hypertension.